Literature DB >> 26617250

Prevalence of multidrug resistant uropathogenic bacteria in pediatric patients of a tertiary care hospital in eastern India.

Monali P Mishra1, Rachita Sarangi2, Rabindra N Padhy3.   

Abstract

Today, because systemic infections such as urinary tract infection (UTI) affect even pediatric patients, antibiotic resistant bacteria have become a constant clinical challenge. In the present study, a total of 1054 urine samples were collected from pediatric patients over 18 months. From these samples, 510 isolates of pathogenic bacteria were collected using HiCrome UTI agar. Antibiotic sensitivity tests of isolates were performed using the Kirby-Bauer method. Two Gram-positive bacteria (Enterococcus faecalis and Staphylococcus aureus) and 7 Gram-negative bacteria (Citrobacter freundii, Enterobacter aerogenes, Escherichia coli, Klebsiella oxytoca, K. pneumoniae, Proteus vulgaris and Pseudomonas aeruginosa) were isolated. Antibiograms of isolated bacteria were ascertained using antibiotics of 4 classes: aminoglycosides, β-lactams, fluoroquinolones and 2 stand-alones (co-trimoxazole and nitrofurantoin). Based on percent values of antibiotic resistance, isolated bacteria were (in decreasing order of number of isolated isolates): E. coli (109)>S. aureus (65)>E. faecalis (82)>E. aerogenes (64)>C. freundii (41)>P. aeruginosa (32)>K. pneumoniae (45)>K. oxytoca (50)>P. vulgaris (22). Surveillance results show that MDR isolates of 9 pathogenic bacteria were prevalent in the environment around the hospital. Thus, revisions to the antimicrobial stewardship program in this area of the country are required to increase clinician confidence in empiric therapy, which is often used for UTI cases.
Copyright © 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Community; Multidrug resistance; Pediatric UTI; Urinary tract infection

Mesh:

Year:  2015        PMID: 26617250     DOI: 10.1016/j.jiph.2015.10.002

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  6 in total

1.  CIPROFLOXACIN RESISTANCE PATTERN AMONG BACTERIA ISOLATED FROM PATIENTS WITH COMMUNITY-ACQUIRED URINARY TRACT INFECTION.

Authors:  Ana Carolina Costa Reis; Susana Regia da Silva Santos; Siane Campos de Souza; Milena Góes Saldanha; Thassila Nogueira Pitanga; Ricardo Riccio Oliveira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-07-11       Impact factor: 1.846

2.  Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.

Authors:  Elsa Roldan-Masedo; Talia Sainz; Almudena Gutierrez-Arroyo; Rosa Maria Gomez-Gil; Estefania Ballesteros; Luis Escosa; Fernando Baquero-Artigao; Ana Méndez-Echevarría
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-29       Impact factor: 3.267

3.  Oxidative stress, DNA, and membranes targets as modes of antibacterial and antibiofilm activity of facile synthesized biocompatible keratin-copper nanoparticles against multidrug resistant uro-pathogens.

Authors:  Satarupa Banerjee; Kumari Vishakha; Shatabdi Das; Priyanka D Sangma; Sandhimita Mondal; Arnab Ganguli
Journal:  World J Microbiol Biotechnol       Date:  2022-01-06       Impact factor: 3.312

4.  Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur, Nepal.

Authors:  Ganendra Bhakta Raya; Bhim Gopal Dhoubhadel; Dhruba Shrestha; Sunayana Raya; Ujjwal Laghu; Ashok Shah; Bijendra Bhakta Raya; Rita Kafle; Christopher M Parry; Koya Ariyoshi
Journal:  Trop Med Health       Date:  2020-08-03

5.  Uropathogenic Escherichia coli virulence characteristics and antimicrobial resistance amongst pediatric urinary tract infections.

Authors:  Narjes Alfuraiji; Amal Al-Hamami; Maysaa Ibrahim; Hassan Khuder Rajab; Balsam Waleed Hussain
Journal:  J Med Life       Date:  2022-05

Review 6.  Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review.

Authors:  Adhi Kristianto Sugianli; Franciscus Ginting; Ida Parwati; Menno D de Jong; Frank van Leth; Constance Schultsz
Journal:  JAC Antimicrob Resist       Date:  2021-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.